Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Zhongguo Gu Shang ; 36(7): 614-8, 2023 Jul 25.
Article Zh | MEDLINE | ID: mdl-37475623

OBJECTIVE: To investigate the risk factors of elbow stiffness after open reduction and internal fixation of intercondylar fracture of humerus. METHODS: From March 2015 to February 2019, 120 patients with humeral intercondylar fractures were treated with open fixation including 59 males and 61 females, aged from 25 to 77 years with an average of(53.5±3.2) years. According to the occurrence of elbow stiffness after operation, 120 patients were divided into stiffness group(37 cases) and control group(83 cases). The related factors of elbow stiffness were analyzed by single factor analysis, and the risk of elbow stiffness after internal fixation of humeral intercondylar fracture was analyzed by logistic regression factor. RESULTS: There were 37 cases of elbow stiffness(stiff group), and 83 cases had no elbow stiffness(control group). The incidence of joint stiffness was 30.83%. There were significant differences between the stiffness group and the control group in age, injury energy, fracture to operation time, AO classification of fracture, open injury and postoperative premature or hyperactivity. Multivariate logistic regression analysis showed that age>50 years old, high energy injury, AO classification of fracture, open fracture and postoperative premature or hyperactivity were risk factors for elbow stiffness after internal fixation of humeral intercondylar fracture. The postoperative mobility and Mayo elbow performance score(MEPS) scores of the postoperative stiffness group were lower than those of the non-stiffness group with statistical significance(P<0.05). There were no significant differences in postoperative mobility and MEPS scores between flexion stiffness and rotation stiffness after humeral intercondylar fracture(P>0.05). CONCLUSION: In view of the risk factors of elbow stiffness after internal fixation of humeral intercondylar fracture, reasonable operation plan and rehabilitation strategy should be formulated before operation to minimize the incidence of elbow stiffness.


Elbow Joint , Fractures, Open , Humeral Fractures , Joint Diseases , Male , Female , Humans , Middle Aged , Elbow , Treatment Outcome , Humerus , Humeral Fractures/surgery , Fracture Fixation, Internal , Elbow Joint/surgery , Risk Factors , Range of Motion, Articular , Retrospective Studies
2.
Zhong Yao Cai ; 35(4): 603-7, 2012 Apr.
Article Zh | MEDLINE | ID: mdl-23019909

OBJECTIVE: To study the mechanism of protective effect of Fagopyrum cymosum on lung injury induced by Klebsiella pneumonia in rats. METHODS: The model of rats with Klebsiella pneumonia was established. The male SD rats were randomly divided into control group, model group, Fagopyrum cymosum (6, 3, 1.5 g/kg) three groups, levofloxacin (25 mg/kg) group. The pathological change of lung was observed. The content of IL-1beta, IL-6, IL-8, TNF-alpha, ICAM-1, INF-gamma in serum were measured by radioimmunoassay and Elisa. TNF-alpha, ICAM-1, NF-kappaB p65 protein expressions were measured by immunohistochemistry. MIP-2mRNA expression was detected by in situ hybridization. RESULTS: The rats of model group had obvious lung injury, but those of Fagopyrum cymosum and levofloxacin groups had less injury. The contents of IL-1beta, IL-6, IL-,8, TNF-alpha, ICAM-1 and INF-gamma in serum and the expressions of TNF-a, ICAM-1, NF-kappaB p65 and MIP--2mRNA of model group were significantly higher than those of the control group (P < 0.05 or P < 0.01), while the indexes of Fagopyrum cymosum and levofloxacin groups were significantly lower than those of model group (P < 0.05 or P < 0.01). CONCLUSION: The lung injury induced by Klebsiella pneumonia is related to TNF-alpha, ICAM-1, NF-kappaB p65 and MIP-2mRNA. To decrease the excessive expression of TNF-alpha, ICAM-1, NF-kappaB p65 and MIP-2mRNA might be the main mechanism of protective effect of Fagopyrum cymosum on lung injury.


Cytokines/metabolism , Drugs, Chinese Herbal/administration & dosage , Fagopyrum , Klebsiella Infections/drug therapy , Lung/metabolism , Pneumonia, Bacterial/drug therapy , Animals , Chemokine CXCL2/genetics , Chemokine CXCL2/metabolism , Cytokines/blood , Disease Models, Animal , Drugs, Chinese Herbal/pharmacology , Fagopyrum/chemistry , Immunohistochemistry , Klebsiella Infections/blood , Klebsiella Infections/metabolism , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Levofloxacin , Lung/drug effects , Lung/microbiology , Male , Ofloxacin/administration & dosage , Ofloxacin/pharmacology , Pneumonia, Bacterial/blood , Pneumonia, Bacterial/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
...